4.7 Article

Fibroblast-led cancer cell invasion is activated by epithelial mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma

Journal

CANCER LETTERS
Volume 395, Issue -, Pages 20-30

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2017.02.026

Keywords

Epithelial-mesenchymal transition; Cancer-associated fibroblasts; Fibroblast-dependent cancer invasion; Extracellular matrix remodeling; Platelet-derived growth factor B

Categories

Funding

  1. National Cancer Center Research and Development Fund [23-A-12]
  2. Foundation for the Promotion of Cancer Research
  3. 3rd Term Comprehensive 10-Year Strategy for Cancer Control [H22-009]
  4. Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation [09-18]
  5. JSPS KAKENHI [24659185]
  6. Grants-in-Aid for Scientific Research [16J11454] Funding Source: KAKEN

Ask authors/readers for more resources

Cancer-associated fibroblast (CAF)-dependent local invasion is the process by which cancer cells invade the extracellular matrix using tracks that have been physically remodeled by CAFs. In the present study, we investigated the process by which the epithelial mesenchymal transition (EMT) of cancer cells affect CAF dependent local invasion. Using an in vitro collagen invasion assay, we showed cancer cells undergoing EMT to promote the matrix-remodeling ability of CAFs and thereby enhance CAF -dependent local cancer cell invasion. Platelet-derived growth factor (PDGF)-BB secretion was significantly elevated in cancer cells undergoing EMT, and this induced an increase in the invasion ability of both CAFs and cancer cells. Conversely, knockdown of PDGF-B expression in cancer cells undergoing EMT, or treatment with a PDGF-receptor inhibitor, decreased the invasion ability of both CAFs and cancer cells. By analyzing the gene expression profiles of 442 patients with lung adenocarcinomas, we established that high expression of PDGF-B and presentation of mesenchymal-like tumors were significantly associated with a high rate of disease recurrence and poor patient prognosis. Thus, cancer cells undergoing EMT may accelerate their own ability to invade local tissues via PDGF-BB secretion to promote CAF matrix remodeling. Therefore, targeting PDGF signaling between cancer cells undergoing EMT and CAFs is a promising therapeutic target to inhibit cancer progression and improve patient prognosis. (C) 2017 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available